PedAM
Pediatric Disease Annotations & Medicines
| Disease | autistic disorder |
| Phenotype | C0041696|major depressive disorder |
| Sentences | 1 |
| PubMedID- 23947389 | Results: the impact study is a 4-site, six month, randomized, open-label, clinical trial of overweight/obese youth ages 8-19 years with pediatric schizophrenia-spectrum and bipolar-spectrum disorders, psychotic or non-psychotic major depressive disorder, or irritability associated with autistic disorder. |
Page: 1